Free Trial

Q3 Earnings Forecast for Core Scientific Issued By B. Riley

Core Scientific logo with Finance background

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Research analysts at B. Riley boosted their Q3 2025 EPS estimates for Core Scientific in a research report issued on Wednesday, July 9th. B. Riley analyst N. Giles now expects that the company will earn $0.00 per share for the quarter, up from their previous estimate of ($0.02). B. Riley has a "Hold" rating on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. B. Riley also issued estimates for Core Scientific's Q4 2025 earnings at $0.03 EPS.

Several other analysts have also recently commented on the stock. Roth Capital reissued a "neutral" rating and set a $20.00 price target on shares of Core Scientific in a research note on Tuesday. Roth Mkm reissued a "buy" rating and set a $20.00 price target on shares of Core Scientific in a research note on Thursday, June 26th. Canaccord Genuity Group reaffirmed a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a research note on Friday, June 27th. Needham & Company LLC cut shares of Core Scientific from a "moderate buy" rating to a "hold" rating and set a $18.00 price objective on the stock. in a research note on Thursday. Finally, JMP Securities began coverage on shares of Core Scientific in a research note on Thursday, May 22nd. They issued a "market outperform" rating and a $15.00 price objective on the stock. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Core Scientific has an average rating of "Moderate Buy" and an average target price of $18.22.

View Our Latest Stock Analysis on Core Scientific

Core Scientific Price Performance

CORZ opened at $13.18 on Friday. Core Scientific has a one year low of $6.20 and a one year high of $18.63. The company's 50 day simple moving average is $12.14 and its 200-day simple moving average is $11.14. The stock has a market capitalization of $3.93 billion, a P/E ratio of -2.62 and a beta of 6.71.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.02. The firm had revenue of $79.53 million for the quarter, compared to the consensus estimate of $92.04 million. Core Scientific's quarterly revenue was down 55.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.78 earnings per share.

Insider Buying and Selling at Core Scientific

In related news, insider Todd M. Duchene sold 7,759 shares of the firm's stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $12.39, for a total transaction of $96,134.01. Following the sale, the insider directly owned 2,049,689 shares in the company, valued at $25,395,646.71. This trade represents a 0.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Yadin Rozov acquired 110,000 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The shares were bought at an average price of $10.87 per share, for a total transaction of $1,195,700.00. Following the completion of the acquisition, the director owned 475,687 shares of the company's stock, valued at $5,170,717.69. This trade represents a 30.08% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 117,759 shares of company stock worth $1,391,434. Company insiders own 1.40% of the company's stock.

Institutional Investors Weigh In On Core Scientific

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Harbor Capital Advisors Inc. increased its stake in Core Scientific by 45.2% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 242,786 shares of the company's stock valued at $4,144,000 after buying an additional 75,602 shares during the last quarter. Fiduciary Alliance LLC increased its stake in Core Scientific by 10.5% in the 2nd quarter. Fiduciary Alliance LLC now owns 26,307 shares of the company's stock valued at $449,000 after buying an additional 2,492 shares during the last quarter. Red Spruce Capital LLC grew its position in shares of Core Scientific by 161.3% in the 2nd quarter. Red Spruce Capital LLC now owns 33,221 shares of the company's stock valued at $567,000 after acquiring an additional 20,508 shares during the period. Rhumbline Advisers grew its position in shares of Core Scientific by 1.6% in the 1st quarter. Rhumbline Advisers now owns 257,142 shares of the company's stock valued at $1,862,000 after acquiring an additional 4,171 shares during the period. Finally, Anson Funds Management LP bought a new position in shares of Core Scientific in the 1st quarter valued at about $689,000.

About Core Scientific

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Read More

Earnings History and Estimates for Core Scientific (NASDAQ:CORZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Core Scientific Right Now?

Before you consider Core Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.

While Core Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines